<DOC>
	<DOCNO>NCT00003598</DOCNO>
	<brief_summary>RATIONALE : Tretinoin may help cervical neoplasia cell develop normal cervical cell . It yet know whether tretinoin effective placebo prevent cervical cancer patient cervical neoplasia . PURPOSE : Randomized clinical trial study effectiveness tretinoin prevent cervical neoplasia develop cervical cancer .</brief_summary>
	<brief_title>UMCC 9609 Tretinoin Preventing Cancer Cervix Patients With Cervical Neoplasia</brief_title>
	<detailed_description>OBJECTIVES : I . Determine whether topical tretinoin reduces number viral genome copy human papilloma virus ( HPV ) per cell inhibits HPV E6/E7 gene expression patient cervical dysplasia . II . Determine dose tretinoin use definitive trial produce best overall modulation biomarkers . OUTLINE : This randomize , multicenter study . Patients stratify accord cervical intraepithelial neoplasia classification ( II v III ) . Patients randomize 1 4 arm . Arm I : Patients receive low-dose tretinoin topically via cervical cap polyurethane ether foam sponge change daily 4 day . Arm II : Patients receive intermediate-dose tretinoin arm I . Arm III : Patients receive high-dose tretinoin arm I . Arm IV : Patients receive placebo topically arm I therapy . Patients follow 6 month . PROJECTED ACCRUAL : A total 180 patient ( 45 per arm ) accrue study .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Precancerous Conditions</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven cervical dysplasia ( cervical intraepithelial neoplasia II III ) Lesions must delineate colposcopic biopsy No pap smear suspicious invasive carcinoma No positive endocervical curettage PATIENT CHARACTERISTICS : Age : Over 14 Performance status : Karnofsky 80100 % Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Immunologic : No proliferative skin disorder ( e.g. , psoriasis ) No diagnosed autoimmune disorder No allergy tretinoin latex Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception ( except intrauterine device ) 3 month study Normal diet adequate protein carbohydrate intake No inutero exposure diethylstilbesterol No prior malignancy No prior toxic shock syndrome PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : At least 1 week since prior tretinoin No prior retinoids ( great 25,000 IU vitamin A equivalent least 3 month ) No tretinoin 3 month study Endocrine therapy : No concurrent regular steroid Radiotherapy : Not specify Surgery : See Disease Characteristics Other : No concurrent regular anticoagulant medication No concurrent nutritional supplement 2 multivitamin per day</criteria>
	<gender>Female</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>cervical cancer</keyword>
	<keyword>cervical intraepithelial neoplasia grade 2</keyword>
	<keyword>cervical intraepithelial neoplasia grade 3</keyword>
</DOC>